India Business Forum

Search Button

The Indian Express

The Financial Express

Latest News

EIW

Market Indicators

Screen

Celebrity Chat

Express Computers

Express Power

Advertisers Forum

Express Careers

Business Forum

Match Maker

Express Properties

Palki - Travel & Tours

Information Technology

Astrosurf

Eco-India

Dr Know

Morning Digest

Graffiti

Crossword

Drumbeat: Ad Buzzaar


Corporate

Economy

Expressions

Markets

Leisure

 

Monday, August 17, 1998

Final hearing of Centre-Glaxo dispute set for next week 

PRESS TRUST OF INDIA  
New Delhi, Aug 16: The 17-year-old dispute between the government and Glaxo India over the recovery of about Rs 189.44 crore from the latter might see the end soon with the Delhi high court fixing the final hearing in the case for next week.

The government had ordered for recovery of the money from the company claiming it had charged more than the fixed price while selling the bulk drugs betamethasone alcohol, betamethasone valearate and betmethasone-di-sodium phosphate.

A division bench of justice RC lahoti and justice C Kmahajan fixed August 18 for concluding reply by senior lawyer Fali S Nariman, appearing for Glaxo India after additional solicitor general CS Vaidyanathan assisted by standing counsel Meera Bhatia finished arguments Wednesday on a revision petition by the company, challenging the recovery on the ground that price fixation in government's drugs prices control orders of 1979, was "faulty". Glaxo India counsel claimed that the government had not indicated the specific provision of DPCOunder which the recovery of the money was being sought and the government agreeing to revise the prices of drugs in question thrice since 1981, showed that it conceded the price fixed previously was `erroneous'.

The government, however, maintained that the prices were worked out as per the cost audit reports, company data and the average figures from 1980 to 1984.

The government claimed that Glaxo India had accepted the revised prices and the Department of Chemical and Fertilisers (DCF) was free to work out the subsequent revisions after an order was passed by the high court in November 1986.

Glaxo India counsel said the interim order of the high court did not prevent the government from invoking the provisions of 1979 DPCO, but during the entire period the DCF neither raised any demand nor indicated that any amount was payable into the drug price equalisation account.

No distinct or separate price was allowed to Glaxo India under the control order while an alternative scheme adopted by the companywas approved on a package basis, counsel contended. The Department of Chemicals and Fertilisers should not have made any demand for the recovery of Rs 30 crore, or fix the prices because of the high court stay between May, 1981, and November, 1986, towards the liability for payment, he said.

Copyright © 1998 Indian Express Newspapers (Bombay) Ltd.


Top


The Ambassador Group of Hotels

Global Tenders invited by MSTC

The National Stock Exchange of India (NSE)

 

Click here for a printer-friendly page Printer-friendly page

An independent investment information and credit rating agency


The Indian Express  |  The Financial Express  |  Latest News
Screen  |  Express Investment Week  |  Market Indicators  |  Express Computers
Astrosurf  |  Eco-India  |  Travel & Tourism  |  Information Technology  |  Drumbeat: Ad Buzzaar
Advertisers Forum  |  Career India  |  Business Forum  |  Match Maker  |  Express Properties